Concord International Investments is a private equity general partner firm with offices in Egypt, Japan and United States.
Valeant Pharmaceuticals International is in talks to buy VC-backed Amoun Pharmaceutical in a deal valuing the Egyptian drug maker at $750m.
Read more news concerning Concord International Investments
Registration is fast, free and easy
Already a member?